-
1
-
-
0029119740
-
Cell cycle control in mammalian cells: Role of cyclins, cyclin dependent kinases (CDKs), growth suppressor genes and cyclin dependent kinase inhibitors
-
Grana X, Reddy EP. Cell cycle control in mammalian cells: role of cyclins, cyclin dependent kinases (CDKs), growth suppressor genes and cyclin dependent kinase inhibitors. Oncogene 1995;11:211-9.
-
(1995)
Oncogene
, vol.11
, pp. 211-219
-
-
Grana, X.1
Reddy, E.P.2
-
3
-
-
0028171292
-
GI phase progression: Cyclin on cue
-
Sher C. GI phase progression: cyclin on cue. Cell 1994; 79:551-5.
-
(1994)
Cell
, vol.79
, pp. 551-555
-
-
Sher, C.1
-
4
-
-
0032980308
-
The prognostic significance of altered cyclin-dependent kinase inhibitors in cancer
-
Tsihlias J. The prognostic significance of altered cyclin-dependent kinase inhibitors in cancer. Annu Rev Med 1999;50:401-23.
-
(1999)
Annu Rev Med
, vol.50
, pp. 401-423
-
-
Tsihlias, J.1
-
5
-
-
0028931265
-
Principles of CDK regulation
-
Morgan DO. Principles of CDK regulation. Nature 1995;374:131-4.
-
(1995)
Nature
, vol.374
, pp. 131-134
-
-
Morgan, D.O.1
-
6
-
-
0030947356
-
High level expression of p27 kip1 and cyclin D in some human breast cancer cell: Inverse correlation between the expression of p27 kip1 and degree of malignancy in human breast and colorectal cancers
-
Fredersdorf S, Burns J, Milne A et al. High level expression of p27 kip1 and cyclin D in some human breast cancer cell: inverse correlation between the expression of p27 kip1 and degree of malignancy in human breast and colorectal cancers. Proc Natl Acad Sci USA 1997; 94:6380-5.
-
(1997)
Proc Natl Acad Sci USA
, vol.94
, pp. 6380-6385
-
-
Fredersdorf, S.1
Burns, J.2
Milne, A.3
-
7
-
-
0031048236
-
Increased proteosome-dependent kinase inhibitor p27 in aggressive colorectal carcinomas
-
Loda M, Cucor B, Tam S et al. Increased proteosome-dependent kinase inhibitor p27 in aggressive colorectal carcinomas. Nat Med 1997;3:231-4.
-
(1997)
Nat Med
, vol.3
, pp. 231-234
-
-
Loda, M.1
Cucor, B.2
Tam, S.3
-
8
-
-
0031048716
-
Expression of cell-cycle regulatory p27 and cyclin E, alone and in combination correlate with survival in young breast cancer patients
-
Porter PL, Malone KE, Heagery PJ et al. Expression of cell-cycle regulatory p27 and cyclin E, alone and in combination correlate with survival in young breast cancer patients. Nat Med 1997;3:222-5.
-
(1997)
Nat Med
, vol.3
, pp. 222-225
-
-
Porter, P.L.1
Malone, K.E.2
Heagery, P.J.3
-
9
-
-
14444268041
-
Prognostic role of the cyclin-dependent kinase inhibitor p27 in non-small cell lung cancer
-
Esposito V, Baldi A, De-Luca A et al. Prognostic role of the cyclin-dependent kinase inhibitor p27 in non-small cell lung cancer. Cancer Res 1997;57:3381-5.
-
(1997)
Cancer Res
, vol.57
, pp. 3381-3385
-
-
Esposito, V.1
Baldi, A.2
De-Luca, A.3
-
10
-
-
0033986568
-
kip1 protein expression and spontaneous apoptosis in patients with colorectal adenocarcinoma
-
kip1 protein expression and spontaneous apoptosis in patients with colorectal adenocarcinoma. Oncology 2000;58:45-51.
-
(2000)
Oncology
, vol.58
, pp. 45-51
-
-
Tenjo, T.1
Toyoda, M.2
Okuda, J.3
-
11
-
-
0032005978
-
Loss of cyclin-dependent kinase inhibitor p27kip1 is a novel prognostic factor in localized prostate adenocarcinomas
-
Tsihlias J, Kapusta LR, DeBoer G et al. Loss of cyclin-dependent kinase inhibitor p27kip1 is a novel prognostic factor in localized prostate adenocarcinomas. Cancer Res 1998;58:542-54.
-
(1998)
Cancer Res
, vol.58
, pp. 542-554
-
-
Tsihlias, J.1
Kapusta, L.R.2
DeBoer, G.3
-
12
-
-
0010985684
-
Tumor suppressor genes: New pathways in gynecological cancer
-
Tidy JA, Wrede D. Tumor suppressor genes: new pathways in gynecological cancer. Int J Gynecol Cancer 1992;2:1-8.
-
(1992)
Int J Gynecol Cancer
, vol.2
, pp. 1-8
-
-
Tidy, J.A.1
Wrede, D.2
-
15
-
-
0141581702
-
Expression of cyclin E and p27 in cervical carcinoma
-
Kim YT, Choi EK, Cho NH et al. Expression of cyclin E and p27 in cervical carcinoma. Cancer Lett 2000;153:41-50.
-
(2000)
Cancer Lett
, vol.153
, pp. 41-50
-
-
Kim, Y.T.1
Choi, E.K.2
Cho, N.H.3
-
17
-
-
0032932656
-
Aberrant expression of the cycle associated proteins TP53, MDM2, p21, cdk4, cyclin D1, Rb and EGFR in cervical carcinomas
-
Skomedal H, Kristensen GB, Lie AK, Holm R. Aberrant expression of the cycle associated proteins TP53, MDM2, p21, cdk4, cyclin D1, Rb and EGFR in cervical carcinomas. Gynecol Oncol 1999;73:223-8.
-
(1999)
Gynecol Oncol
, vol.73
, pp. 223-228
-
-
Skomedal, H.1
Kristensen, G.B.2
Lie, A.K.3
Holm, R.4
-
18
-
-
0035023942
-
The role of p27 in endometrial carcinoma
-
Nycum LR, Smith LM, Farley JH, Kost ER, Method MW, Birer MJ. The role of p27 in endometrial carcinoma. Gynecol Oncol 2001;81:242-6.
-
(2001)
Gynecol Oncol
, vol.81
, pp. 242-246
-
-
Nycum, L.R.1
Smith, L.M.2
Farley, J.H.3
Kost, E.R.4
Method, M.W.5
Birer, M.J.6
-
19
-
-
0033018797
-
Strongly reduced expression of the cell cycle inhibitor in endometrial neoplasia
-
Barnberger A, Riethdorf L, Langosh K et al. Strongly reduced expression of the cell cycle inhibitor in endometrial neoplasia. Virchows Arch 1999;434:423-8.
-
(1999)
Virchows Arch
, vol.434
, pp. 423-428
-
-
Barnberger, A.1
Riethdorf, L.2
Langosh, K.3
-
20
-
-
0034123121
-
p27 and cyclin D1 abnormalities in uterine papillary serous carcinoma
-
Schmitz MJ, Hendricks DT, Farley J et al. p27 and cyclin D1 abnormalities in uterine papillary serous carcinoma. Gynecol Oncol 2000;77:439-5.
-
(2000)
Gynecol Oncol
, vol.77
, pp. 439-435
-
-
Schmitz, M.J.1
Hendricks, D.T.2
Farley, J.3
-
21
-
-
0035998397
-
kip1 and Ki-67 expression provide independent information on overall survival of ovarian carcinoma patients
-
kip1 and Ki-67 expression provide independent information on overall survival of ovarian carcinoma patients. Gynecol Oncol 2002;85:404-14.
-
(2002)
Gynecol Oncol
, vol.85
, pp. 404-414
-
-
Korkolopoulou, P.1
Vassilopoulus, I.2
Konstatinidou, A.E.3
-
23
-
-
17444427662
-
Frequent loss of expression of the cyclin-dependent kinase inhibitor p27 in epithelial ovarian cancer
-
Masciullo V, Sgambato A, Pacilio C et al. Frequent loss of expression of the cyclin-dependent kinase inhibitor p27 in epithelial ovarian cancer. Cancer Res 1999;59:3790-4.
-
(1999)
Cancer Res
, vol.59
, pp. 3790-3794
-
-
Masciullo, V.1
Sgambato, A.2
Pacilio, C.3
-
24
-
-
0032723348
-
Lack of independent prognostic significance of p21 and p27 expression in advanced ovarian cancer: An immunohistochemical study
-
Baeckelandt M, Holm R, Trope CG, Nesland JM, Kristensen GB. Lack of independent prognostic significance of p21 and p27 expression in advanced ovarian cancer: an immunohistochemical study. Clin Cancer Res 1999;5:2848-53.
-
(1999)
Clin Cancer Res
, vol.5
, pp. 2848-2853
-
-
Baeckelandt, M.1
Holm, R.2
Trope, C.G.3
Nesland, J.M.4
Kristensen, G.B.5
-
25
-
-
0034791332
-
kip1, cyclin E, and cdk2 expression in epithelial ovarian tumors
-
kip1, cyclin E, and cdk2 expression in epithelial ovarian tumors. Gynecol Onco 2001; 83:56-63.
-
(2001)
Gynecol Onco
, vol.83
, pp. 56-63
-
-
Sui, L.1
Dong, Y.2
Ohno, M.3
-
26
-
-
0031964464
-
Carcinosarcoma (malignant mixed müllerian tumors) of the genital tract: Comparative molecular analysis of epithelial and mesenchimal components
-
Kounelis S, Jones MW, Papadaki H, Bakker A, Swalsky P, Finkelstein SD. Carcinosarcoma (malignant mixed müllerian tumors) of the genital tract: comparative molecular analysis of epithelial and mesenchimal components. Hum Pathol 1998;29:82-7.
-
(1998)
Hum Pathol
, vol.29
, pp. 82-87
-
-
Kounelis, S.1
Jones, M.W.2
Papadaki, H.3
Bakker, A.4
Swalsky, P.5
Finkelstein, S.D.6
-
27
-
-
0031595123
-
Malignant mixed müllerian tumor of the uterus. Feature favoring its origin from a common cell clone and an epithelial to mesenchimal transformation of histogenesis
-
Guarino M, Giordano F, Pallotti F, Polizzoti G, Tricomi P, Cristofori E. Malignant mixed müllerian tumor of the uterus. Feature favoring its origin from a common cell clone and an epithelial to mesenchimal transformation of histogenesis. Tumori 1998;84:391-7.
-
(1998)
Tumori
, vol.84
, pp. 391-397
-
-
Guarino, M.1
Giordano, F.2
Pallotti, F.3
Polizzoti, G.4
Tricomi, P.5
Cristofori, E.6
-
28
-
-
0032895230
-
Co-expression of p53 by epithelial and stromal elements in carcinosarcoma of the female genital tract: An immunohistochemical study of 19 cases
-
Szukala SA, Marks JR, Burchette JL, Elbendary Krigman HR. Co-expression of p53 by epithelial and stromal elements in carcinosarcoma of the female genital tract: an immunohistochemical study of 19 cases. In J Gynecol Cancer 1999;9:131-6.
-
(1999)
In J Gynecol Cancer
, vol.9
, pp. 131-136
-
-
Szukala, S.A.1
Marks, J.R.2
Burchette, J.L.3
Elbendary Krigman, H.R.4
-
29
-
-
0031963294
-
Cancer statistics, 1998
-
Landis SH, Muray T, Bolden S, Wingo PA. Cancer statistics, 1998. CA Cancer J Clin 1998;48:6-30.
-
(1998)
CA Cancer J Clin
, vol.48
, pp. 6-30
-
-
Landis, S.H.1
Muray, T.2
Bolden, S.3
Wingo, P.A.4
-
30
-
-
0035991014
-
The prognostic relevance of histological type in uterine sarcomas: A Cooperation Task Force (CTF) multivariate analysis of 249 cases
-
Gaddducci A, Sartori E, Landoni F et al. The prognostic relevance of histological type in uterine sarcomas: a Cooperation Task Force (CTF) multivariate analysis of 249 cases. Eur J Gynecol Oncol 2002;23:295-9.
-
(2002)
Eur J Gynecol Oncol
, vol.23
, pp. 295-299
-
-
Gaddducci, A.1
Sartori, E.2
Landoni, F.3
-
31
-
-
0036084223
-
Down regulation of p27 is associated with malignant transformation and aggressive phenotype of cervical neoplasms
-
Huang LW, Chao SL, Hwang JL, Chou YY. Down regulation of p27 is associated with malignant transformation and aggressive phenotype of cervical neoplasms. Gynecol Oncol 2002;85:524-8.
-
(2002)
Gynecol Oncol
, vol.85
, pp. 524-528
-
-
Huang, L.W.1
Chao, S.L.2
Hwang, J.L.3
Chou, Y.Y.4
-
32
-
-
0034351879
-
p27 expression is associated with clinical outcome in advanced epithelial ovarian cancer: Multivariate analysis
-
Masciulo V, Ferrandina G, Pucci B et al. p27 expression is associated with clinical outcome in advanced epithelial ovarian cancer: multivariate analysis. Clin Cancer Res 2000;6:4816-22.
-
(2000)
Clin Cancer Res
, vol.6
, pp. 4816-4822
-
-
Masciulo, V.1
Ferrandina, G.2
Pucci, B.3
-
33
-
-
0035056377
-
Evaluation of chemoresistance markers in epithelial ovarian carcinoma
-
Goff BA, Paley PJ, Greer BE, Gown A. Evaluation of chemoresistance markers in epithelial ovarian carcinoma. Gynecol Oncol 2001;81:18-24.
-
(2001)
Gynecol Oncol
, vol.81
, pp. 18-24
-
-
Goff, B.A.1
Paley, P.J.2
Greer, B.E.3
Gown, A.4
-
34
-
-
0026691603
-
p53 expression in neoplasms of the uterine corpus
-
Bur ME, Periman C, Edelman L, Fey E, Rose PG. p53 expression in neoplasms of the uterine corpus. Am J Clin Pathol 1992;98:81-7.
-
(1992)
Am J Clin Pathol
, vol.98
, pp. 81-87
-
-
Bur, M.E.1
Periman, C.2
Edelman, L.3
Fey, E.4
Rose, P.G.5
-
35
-
-
0026504107
-
Overexpression and mutation of p53 in endometrial carcinoma
-
Kohler MF, Berchuk A, Davidoff AM et al. Overexpression and mutation of p53 in endometrial carcinoma. Cancer Res 1992;52:1622-7.
-
(1992)
Cancer Res
, vol.52
, pp. 1622-1627
-
-
Kohler, M.F.1
Berchuk, A.2
Davidoff, A.M.3
-
36
-
-
0028350939
-
Observations on tumor and metastatic suppressor gene status in endometrial carcinoma with particular emphasis on p53
-
Ambros RA, Vigna PA, Figge J et al. Observations on tumor and metastatic suppressor gene status in endometrial carcinoma with particular emphasis on p53. Cancer 1994;73:1686-92.
-
(1994)
Cancer
, vol.73
, pp. 1686-1692
-
-
Ambros, R.A.1
Vigna, P.A.2
Figge, J.3
-
37
-
-
0028301209
-
Clinicopathological characteristics of p53 overexpression in endometrial cancer
-
Inoue M, Okayama A, Fujita M et al. Clinicopathological characteristics of p53 overexpression in endometrial cancer. Int J Cancer 1994;58:14-9.
-
(1994)
Int J Cancer
, vol.58
, pp. 14-19
-
-
Inoue, M.1
Okayama, A.2
Fujita, M.3
-
38
-
-
0030442560
-
MDM2 and p53 protein expression in the subtypes of endometrial carcinoma
-
Ambros RA, Sheehan CE, Kallakury BVS et al. MDM2 and p53 protein expression in the subtypes of endometrial carcinoma. Mol Pathol 1996;9:1165-9.
-
(1996)
Mol Pathol
, vol.9
, pp. 1165-1169
-
-
Ambros, R.A.1
Sheehan, C.E.2
Kallakury, B.V.S.3
-
39
-
-
0036944972
-
p53 expression in tissue adjacent to endometrial carcinoma
-
Ben Shem E, Fintsi Y, Avinoach I, Glezerman M, Menczer J. p53 expression in tissue adjacent to endometrial carcinoma. Eur J Gynecol Oncol 2002;23:548-50.
-
(2002)
Eur J Gynecol Oncol
, vol.23
, pp. 548-550
-
-
Ben Shem, E.1
Fintsi, Y.2
Avinoach, I.3
Glezerman, M.4
Menczer, J.5
-
40
-
-
0035717956
-
Prognostic value of p53, c-erb-B2 and MIB-1 in endometrial carcinoma
-
Cherchi PL, Marras V, Capobianco G et al. Prognostic value of p53, c-erb-B2 and MIB-1 in endometrial carcinoma. Eur J Gynecol Oncol 2001;22:451-3.
-
(2001)
Eur J Gynecol Oncol
, vol.22
, pp. 451-453
-
-
Cherchi, P.L.1
Marras, V.2
Capobianco, G.3
-
41
-
-
0036677674
-
Prognostic significance of Bcl-2, p 53, overexpression and lymph node metastasis in surgically staged endometrial carcinoma
-
Ohkouchi T, Sakuragi N, Watari H et al. Prognostic significance of Bcl-2, p 53, overexpression and lymph node metastasis in surgically staged endometrial carcinoma. Am J Obstet Gynecol 2002;187:353-9.
-
(2002)
Am J Obstet Gynecol
, vol.187
, pp. 353-359
-
-
Ohkouchi, T.1
Sakuragi, N.2
Watari, H.3
-
42
-
-
0032006242
-
Prognostic factors in uterine carcinosarcoma: A clinicopathological study of 25 patients
-
Iwasawa Y, Haga H, Konoshi I et al. Prognostic factors in uterine carcinosarcoma: a clinicopathological study of 25 patients. Cancer 1998;82:512-9.
-
(1998)
Cancer
, vol.82
, pp. 512-519
-
-
Iwasawa, Y.1
Haga, H.2
Konoshi, I.3
-
43
-
-
0031612842
-
Malignant mixed müllerian tumors of the uterus. A clinicopathologic, DNA flow cytometric, p53 and mdm-2 analysis of 44 cases
-
Blom R, Guerrieri C, Stal O, Malmstrom H, Sullivan S, Simonsen E. Malignant mixed müllerian tumors of the uterus. a clinicopathologic, DNA flow cytometric, p53 and mdm-2 analysis of 44 cases. Gynecol Oncol 1998; 68:18-24.
-
(1998)
Gynecol Oncol
, vol.68
, pp. 18-24
-
-
Blom, R.1
Guerrieri, C.2
Stal, O.3
Malmstrom, H.4
Sullivan, S.5
Simonsen, E.6
|